loadpatents
name:-0.055961132049561
name:-0.0434250831604
name:-0.0023870468139648
Curatolo; William J. Patent Filings

Curatolo; William J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Curatolo; William J..The latest application filed is for "pharmaceutical compositions providing enhanced drug concentrations".

Company Profile
1.41.39
  • Curatolo; William J. - Niantic CT
  • Curatolo, William J - Niantic CT
  • Curatolo; William J. - Groton CT
  • Curatolo; William J. - Old Lyme CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical compositions providing enhanced drug concentrations
Grant 9,457,095 - Curatolo , et al. October 4, 2
2016-10-04
Pharmaceutical Compositions Providing Enhanced Drug Concentrations
App 20150190518 - Curatolo; William J. ;   et al.
2015-07-09
Hydrogel-driven drug dosage form
Grant 9,028,870 - Appel , et al. May 12, 2
2015-05-12
Pharmaceutical compositions providing enhanced drug concentrations
Grant 8,980,321 - Curatolo , et al. March 17, 2
2015-03-17
Solid Pharmaceutical Dispersions With Enhanced Bioavailability
App 20150024054 - Curatolo; William J. ;   et al.
2015-01-22
Pharmaceutical Compositions Providing Enhanced Drug Concentrations
App 20140322325 - Curatolo; William J. ;   et al.
2014-10-30
Pharmaceutical compositions providing enhanced drug concentrations
Grant 8,796,341 - Curatolo , et al. August 5, 2
2014-08-05
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
Grant 8,703,196 - Babcock , et al. April 22, 2
2014-04-22
Pharmaceutical Compositions Providing Enhanced Drug Concentrations
App 20130345236 - Curatolo; William J. ;   et al.
2013-12-26
Solid Pharmaceutical Dispersions With Enhanced Bioavailability
App 20130224301 - Curatolo; William J. ;   et al.
2013-08-29
Pharmaceutical compositions providing enhanced drug concentrations
Grant 8,501,231 - Curatolo , et al. August 6, 2
2013-08-06
Solid pharmaceutical dispersions with enhanced bioavailability
Grant 8,431,159 - Curatolo , et al. April 30, 2
2013-04-30
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
Grant 8,389,011 - Crew , et al. March 5, 2
2013-03-05
Solid pharmaceutical dispersions with enhanced bioavailability
Grant 8,367,118 - Curatolo , et al. February 5, 2
2013-02-05
Solid Pharmaceutical Dispersions With Enhanced Bioavailability
App 20120328679 - Curatolo; William J. ;   et al.
2012-12-27
Solid pharmaceutical dispersions with enhanced bioavailability
Grant 8,337,899 - Curatolo , et al. December 25, 2
2012-12-25
Solid Pharmaceutical Dispersions With Enhanced Bioavailability
App 20120292797 - Curatolo; William J. ;   et al.
2012-11-22
Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
App 20120295988 - Babcock; Walter C. ;   et al.
2012-11-22
Solid Pharmaceutical Dispersions With Enhanced Bioavailability
App 20120288542 - Curatolo; William J. ;   et al.
2012-11-15
Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors
App 20120277315 - Crew; Marshall D. ;   et al.
2012-11-01
Pharmaceutical Compositions Providing Enhanced Drug Concentrations
App 20120259022 - Curatolo; William J. ;   et al.
2012-10-11
Solid pharmaceutical dispersions with enhanced bioavailability
Grant 8,263,128 - Curatolo , et al. September 11, 2
2012-09-11
Solid pharmaceutical dispersions with enhanced bioavailability
Grant 8,257,741 - Curatolo , et al. September 4, 2
2012-09-04
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
Grant 8,236,328 - Babcock , et al. August 7, 2
2012-08-07
Pharmaceutical compositions providing enhanced drug concentrations
Grant 8,202,912 - Curatolo , et al. June 19, 2
2012-06-19
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
Grant 8,197,848 - Crew , et al. June 12, 2
2012-06-12
Pharmaceutical Compositions Providing Enhanced Drug Concentrations
App 20110294902 - CURATOLO; William J. ;   et al.
2011-12-01
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
Grant 8,048,452 - Curatolo , et al. November 1, 2
2011-11-01
Pharmaceutical compositions providing enhanced drug concentrations
Grant 8,026,286 - Curatolo , et al. September 27, 2
2011-09-27
Hydrogel-driven Drug Dosage Form
App 20110182947 - Appel; Leah E. ;   et al.
2011-07-28
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
Grant 7,887,840 - Curatolo , et al. February 15, 2
2011-02-15
Controlled release by extrusion of solid amorphous dispersions of drugs
Grant 7,550,158 - Appel , et al. June 23, 2
2009-06-23
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
App 20090011024 - Babcock; Walter C. ;   et al.
2009-01-08
Enteric Coated Azithromycin Multiparticulates
App 20080199527 - Curatolo; William J. ;   et al.
2008-08-21
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
App 20070282009 - Crew; Marshall D. ;   et al.
2007-12-06
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
Grant 7,235,259 - Crew , et al. June 26, 2
2007-06-26
Hydrogel-Driven Drug Dosage Form
App 20070087057 - Appel; Leah E. ;   et al.
2007-04-19
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
Grant 7,115,279 - Curatolo , et al. October 3, 2
2006-10-03
Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor
App 20060211654 - Curatolo; William J. ;   et al.
2006-09-21
Controlled-release dosage forms of azithromycin
Grant 7,108,865 - Curatolo , et al. September 19, 2
2006-09-19
Method of administering azithromycin
Grant RE39,149 - Curatolo , et al. June 27, 2
2006-06-27
Hydrogel-driven layered drug dosage form
Grant 6,899,896 - Curatolo , et al. May 31, 2
2005-05-31
Basic drug compositions with enhanced bioavailability
App 20050049223 - Curatolo, William J. ;   et al.
2005-03-03
Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
App 20050038007 - Curatolo, William J. ;   et al.
2005-02-17
Stable non-dihydrate azithromycin oral suspensions
App 20050013835 - Collier, Steven W. ;   et al.
2005-01-20
Controlled release by extrusion of solid amorphous dispersions of drugs
App 20040175428 - Appel, Leah E. ;   et al.
2004-09-09
Method of increasing the bioavailability and tissue penetration of azithromycin
App 20040091527 - Curatolo, William J. ;   et al.
2004-05-13
Sustained release formulations for growth hormone secretagogues
App 20040091530 - Am Ende, Mary T. ;   et al.
2004-05-13
Hydrogel-driven drug dosage form
App 20040052845 - Appel, Leah E ;   et al.
2004-03-18
Controlled release by extrusion of solid amorphous dispersions of drugs
Grant 6,706,283 - Appel , et al. March 16, 2
2004-03-16
Solid pharmaceutical dispersions with enhanced bioavailability
App 20030219489 - Curatolo, William J. ;   et al.
2003-11-27
Sustained release formulations for growth hormone secretagogues
Grant 6,641,840 - Am Ende , et al. November 4, 2
2003-11-04
Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
App 20030198674 - Curatolo, William J. ;   et al.
2003-10-23
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
App 20030186952 - Crew, Marshall D. ;   et al.
2003-10-02
Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
App 20030104063 - Babcock, Walter C. ;   et al.
2003-06-05
Hydrogel-driven drug dosage form
App 20030086972 - Appel, Leah E. ;   et al.
2003-05-08
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
App 20030072801 - Curatolo, William J. ;   et al.
2003-04-17
Basic drug compositions with enhanced bioavailability
Grant 6,548,555 - Curatolo , et al. April 15, 2
2003-04-15
Sustained release formulations for growth hormone secretagogues
App 20020137765 - Am Ende, Mary T. ;   et al.
2002-09-26
Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
App 20020103225 - Curatolo, William J. ;   et al.
2002-08-01
Controlled- release dosage forms of azithromycin
App 20020044965 - Curatolo, William J. ;   et al.
2002-04-18
Hydrogel-Driven Drug Dosage Form
App 20020015731 - Appel, Leah E. ;   et al.
2002-02-07
Solid pharmaceutical dispersions with enhanced bioavailability
App 20020009494 - Curatolo, William J. ;   et al.
2002-01-24
Method of increasing the bioavailability and tissue penetration of azithromycin
App 20020009433 - Curatolo, William J. ;   et al.
2002-01-24
Pharmaceutical compositions providing enhanced drug concentrations
App 20020006443 - Curatolo, William J. ;   et al.
2002-01-17
Hydrogel-driven layered drug dosage form
App 20010044474 - Curatolo, William J. ;   et al.
2001-11-22
Dispensing devices powered by hydrogel
Grant 5,792,471 - Curatolo August 11, 1
1998-08-11
Method of administering azithromycin
Grant 5,605,889 - Curatolo , et al. February 25, 1
1997-02-25
Dispensing device powered by hydrogel
Grant 5,516,527 - Curatolo May 14, 1
1996-05-14
Gastric retention system for controlled drug release
Grant 5,443,843 - Curatolo , et al. August 22, 1
1995-08-22
Dispensing devices powered by lyotropic liquid crystals
Grant 5,108,756 - Curatolo April 28, 1
1992-04-28
Dispensing devices powered by lyotropic liquid crystals
Grant 5,030,452 - Curatolo July 9, 1
1991-07-09
Gastric retention system for controlled drug release
Grant 5,002,772 - Curatolo , et al. March 26, 1
1991-03-26
Chitosan compositions for controlled and prolonged release of macromolecules
Grant 4,895,724 - Cardinal , et al. January 23, 1
1990-01-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed